Показать сокращенную информацию
dc.contributor.author | Golubev A. | |
dc.contributor.author | Negroni L. | |
dc.contributor.author | Krasnovid F. | |
dc.contributor.author | Validov S. | |
dc.contributor.author | Yusupova G. | |
dc.contributor.author | Yusupov M. | |
dc.contributor.author | Usachev K. | |
dc.date.accessioned | 2021-02-25T20:54:10Z | |
dc.date.available | 2021-02-25T20:54:10Z | |
dc.date.issued | 2020 | |
dc.identifier.uri | https://dspace.kpfu.ru/xmlui/handle/net/162594 | |
dc.description.abstract | © 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. Antibiotic-resistant Staphylococcus aureus is becoming a major burden on health care systems in many countries, necessitating the identification of new targets for antibiotic development. Elongation Factor P (EF-P) is a highly conserved elongation protein factor that plays an important role in protein synthesis and bacteria virulence. EF-P undergoes unique posttranslational modifications in a stepwise manner to function correctly, but experimental information on EF-P posttranslational modifications is currently lacking for S. aureus. Here, we expressed EF-P in S. aureus to analyze its posttranslational modifications by mass spectrometry and report experimental proof of 5-aminopentanol modification of S. aureus EF-P. | |
dc.subject | EF-P | |
dc.subject | posttranslational modifications | |
dc.subject | ribosome | |
dc.subject | stalling | |
dc.subject | Staphylococcus aureus | |
dc.title | Posttranslational modification of Elongation Factor P from Staphylococcus aureus | |
dc.type | Article | |
dc.relation.ispartofseries-issue | 7 | |
dc.relation.ispartofseries-volume | 10 | |
dc.collection | Публикации сотрудников КФУ | |
dc.relation.startpage | 1342 | |
dc.source.id | SCOPUS-2020-10-7-SID85087186292 |